EPIGRAL Stock Overview
Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Epigral Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,295.05 |
| 52 Week High | ₹1,400.00 |
| 52 Week Low | ₹862.05 |
| Beta | -0.39 |
| 1 Month Change | 24.51% |
| 3 Month Change | 30.67% |
| 1 Year Change | 24.23% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 218.62% |
Recent News & Updates
Epigral Limited (NSE:EPIGRAL) Soars 28% But It's A Story Of Risk Vs Reward
Feb 23
Epigral (NSE:EPIGRAL) Might Be Having Difficulty Using Its Capital Effectively
Feb 21Recent updates
Epigral Limited (NSE:EPIGRAL) Soars 28% But It's A Story Of Risk Vs Reward
Feb 23Epigral (NSE:EPIGRAL) Might Be Having Difficulty Using Its Capital Effectively
Feb 21Capital Investment Trends At Meghmani Finechem (NSE:MFL) Look Strong
Apr 05With EPS Growth And More, Meghmani Finechem (NSE:MFL) Makes An Interesting Case
Sep 28Meghmani Finechem's (NSE:MFL) Promising Earnings May Rest On Soft Foundations
May 03Meghmani Finechem Limited's (NSE:MFL) Business Is Yet to Catch Up With Its Share Price
Nov 22Shareholder Returns
| EPIGRAL | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -4.4% | -2.4% | -2.1% |
| 1Y | 24.2% | 17.4% | 45.3% |
Return vs Industry: EPIGRAL exceeded the Indian Chemicals industry which returned 16.9% over the past year.
Return vs Market: EPIGRAL underperformed the Indian Market which returned 45% over the past year.
Price Volatility
| EPIGRAL volatility | |
|---|---|
| EPIGRAL Average Weekly Movement | 7.3% |
| Chemicals Industry Average Movement | 6.4% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: EPIGRAL's share price has been volatile over the past 3 months.
Volatility Over Time: EPIGRAL's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 936 | Kaushal Soparkar | epigral.com |
Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes, hydrogen peroxide, caustic soda, chlorine, hydrogen, and caustic potash products. It also trades in agrochemical products.
Epigral Limited Fundamentals Summary
| EPIGRAL fundamental statistics | |
|---|---|
| Market cap | ₹53.81b |
| Earnings (TTM) | ₹1.95b |
| Revenue (TTM) | ₹19.67b |
27.5x
P/E Ratio2.7x
P/S RatioIs EPIGRAL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EPIGRAL income statement (TTM) | |
|---|---|
| Revenue | ₹19.67b |
| Cost of Revenue | ₹12.24b |
| Gross Profit | ₹7.43b |
| Other Expenses | ₹5.48b |
| Earnings | ₹1.95b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 22, 2024
| Earnings per share (EPS) | 47.01 |
| Gross Margin | 37.79% |
| Net Profit Margin | 9.93% |
| Debt/Equity Ratio | 86.1% |
How did EPIGRAL perform over the long term?
See historical performance and comparison